Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Removing part of the vitamin D receptor stops vitamin D from working properly.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Early balding linked to higher heart disease risk.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Baldness may be linked to heart disease, but the evidence isn't strong enough to consider it a major risk factor.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.